Nonprofits›Mass General Brigham Incorporated
Health Care
Mass General Brigham Incorporated
SOMERVILLE, MA
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$1.9B
1,050 grants
EIN
041564655
Tax year
—
Grants received
Showing 200 of 1,050
FromAmountPurposeYear
$900K
SUPPORT NSW VETERANS, SERVICE MEMBERS, AND THEIR FAMILIES DEALING WITH THE INVISIBLE WOUNDS OF WAR, SUCH AS PTSD AND TBI
2024
$706K
DR. CURRY RESEARCH LAB - TO SUPPORT CANCER RESEARCH, TREATMENT AND CURE, AND TO CREATE AWARENESS OF THE DISEASE AND/OR RELATED DISEASE(S).
2024
$288K
MBC: MICROBIAL PROFILING OF HUMAN BRAIN AND GUT MICROBIOMES IN ALZHEIMER'S DISEASE.
2024
$288K
BEE: HUMAN 3D NEURO-VASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO ALZHEIMER'S DISEASE
2024
$230K
ADAM10 CLEAVAGE OF APP: PHYSIOLOGICAL FUNCTION IN BRAIN AND THERAPEUTIC POTENTIAL FOR ALZHEIMER'S DISEASE
2024
$228K
To provide funding for data to support grant writing activities for the Translational Brain Tumor Immunology Lab (TBTIL)
2024
$201K
VALIDATION AND CHARACTERIZATION OF COMPOUNDS MODULATING NEUROINFLAMMATION AND AMYLOID BETA UPTAKE IN MICROGLIAL CELLS
2024
$201K
EXPLORING NOVEL DRUG CANDIDATES FOR ALZHEIMER'S DISEASE THROUGH INTEGRATIVE PATHWAY ANALYSIS AND VALIDATION IN 3D CELLULAR MODELS
2024
$201K
CHARACTERIZING GUT BACTERIOME-MYCOBIOME SYNERGY IN CORRELATION TO AMYLIN-AB ANTIMICROBIAL SYNERGY IN ALZHEIMER'S DISEASE (AD) IN AD MOUSE MODELS
2024
$201K
CHARACTERIZATION OF CNS-PENETRANT HDAC 11 SELECTIVE INHIBITORS IN ALZHEIMER'S DISEASE MODELS
2024
$201K
ROLE OF RIN3 AND BIN1 INTERACTION IN THE NEURONS FOR ALZHEIMER'S DISEASE DEVELOPMENT
2024
$201K
ROLE OF CD8+ T CELL-GLIAL INTERACTIONS IN MEDIATING ALZHEIMER'S DISEASE PATHOGENESIS
2024
$201K
TAU AND B-AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN
2024
$201K
ROLE OF STABILIZATION OF MAMS AND MAM-ASSOCIATED PALMITOYLATED APP (MAM-PALAPP) IN ALZHEIMER'S DISEASE
2024
$200K
TO SUPPORT THE UNDIAGNOSED DISEASE PROGRAM AT MASS GENERAL HOSPITAL.
2024
$188K
Alzheimer's and ALS research consistent with our organization's mission to fund research into the prevention and cure of Alzheimer's and ALS
2024
$173K
NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE
2024
$125K
THE IMPACT OF MUTATIONS IN THE LIGAND-BINDING DOMAIN OF CD33 ON ALZHEIMER'S DISEASE PATHOGENESIS
2024
$100K
CANCER OUTCOMES RESEARCH AND EDUCATION (CORE) PALLIATIVE CARE PROGRAM
2024
$50K
In support of the Brain Science Meningioma Fund and general support
2024
$50K
Advance NF research projects at Grant Walker Lab, Massachusetts General Hospital
2024
$48K
Fellowship award for salary, benefits and supplies for Fellow training in the clinical treatment of and research pertaining to rare neuroiummune diseases and a second grant to investigate Headache and Eye Pain Associated with Rare Neuroimmune Disorders
2024
$30K
NON-INVASIVE GENOMIC TESTING OF LARGE AND GIANT CONGENITAL NEVI
2024
$20K
ASSIST WITH THE NEEDS OF VETERANS AND THEIR FAMILIES, WITH THE FOCUS ON HOUSING, EDUCATION, AND MENTAL HEALTH
2024
$13K
2024 Quality Improvement Care Coordination Grant - $13000
2024
$9K
FOR SUPPORT OF THE CHRIS TOMLINSON FUND RAISING PAGE # 5911809 AT THE REQUEST OF SARAH R. AND PHILIP M. BOGDANOVITCH
2024
$1.4M
THINK KIDS & MEADOWS MENTAL HEALTH POLICY INSTITUTE COLLABORATIVE PRIMARY CARE PROJECT
2023
$1.4M
THINK KIDS & MEADOWS MENTAL HEALTH POLICY INSTITUTE COLLABORATIVE PRIMARY CARE PROJECT
2023
$500K
DR. CURRY RESEARCH LAB - TO SUPPORT CANCER RESEARCH, TREATMENT AND CURE, AND TO CREATE AWARENESS OF THE DISEASE AND/OR RELATED DISEASE(S).
2023
$500K
DR. CURRY RESEARCH LAB - TO SUPPORT CANCER RESEARCH, TREATMENT AND CURE, AND TO CREATE AWARENESS OF THE DISEASE AND/OR RELATED DISEASE(S).
2023
$345K
NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE
2023
$300K
UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY
2023
$288K
MBC: MICROBIAL PROFILING OF HUMAN BRAIN AND GUT MICROBIOMES IN ALZHEIMER'S DISEASE
2023
$259K
FUNCTIONAL CHANGES TO CEREBROSPINAL FLUID IMMUNE CELLS RESULTING FROM BACILLUS CALMETTE-GURIN (BCG) VACCINATION IN OLDER ADULTS WITH AND WITHOUT ALZHEIMER'S DISEASE
2023
$250K
CANCER OUTCOMES RESEARCH AND EDUCATION (CORE) PALLIATIVE CARE PROGRAM
2023
$230K
BEE: A 3D IN-VITRO NEURO-VASCULAR HUMAN BRAIN MODEL WITH MENINGEAL LYMPHATICS FOR ELUCIDATING MECHANISMS UNDERLYING ALZHEIMER'S DISEASE
2023
$201K
ROLE OF CD8+ T CELL-GLIAL INTERACTIONS IN MEDIATING ALZHEIMER'S DISEASE PATHOGENESIS
2023
$201K
ROLE OF RIN3 AND BIN1 INTERACTION IN THE NEURONS FOR ALZHEIMER'S DISEASE DEVELOPMENT
2023
$201K
CHARACTERIZING GUT BACTERIOME-MYCOBIOME SYNERGY IN CORRELATION TO AMYLIN-A ANTIMICROBIAL SYNERGY IN ALZHEIMER'S DISEASE (AD) IN AD MOUSE MODELS
2023
$201K
ROLE OF STABILIZATION OF MAMS AND MAM-ASSOCIATED PALMITOYLATED APP (MAM-PALAPP) IN ALZHEIMER'S DISEASE
2023
$201K
CHARACTERIZATION OF CNS-PENETRANT HDAC11-SELECTIVE INHIBITORS IN ALZHEIMER'S DISEASE MODELS
2023
$201K
GROWTH, CHARACTERIZATION, AND DISTRIBUTION OF A NEURODEGENERATIVE DISEASE-FOCUSED FIBROBLAST/IPS CELL BANK TO SUPPORT MOLECULAR MODELS OF PATIENT-SPECIFIC VARIATION WITH VALIDATION IN MATCHED DONATED BRAIN TISSUES
2023
$201K
VALIDATION AND CHARACTERIZATION OF COMPOUNDS MODULATING NEUROINFLAMMATION AND AMYLOID BETA UPTAKE IN MICROGLIAL CELLS
2023
$200K
TO SUPPORT THE UNDIAGNOSED DISEASE PROGRAM AT MASS GENERAL HOSPITAL.
2023
$195K
SUPPORT PEDIATRIC CARDIAC SURGERIES, PROVIDE TRAINING FOR EMERGENCY CARE WORKERS, TO EFFECTIVELY DIAGNOSE AND RESPOND TO PEDIATRIC HEART CARE NEEDS, CREATING AN UPLIFTING DIAGNOSIS AND TREATMENT SPACE, AND PROVIDING CHILD LIFE SPECIALIST SUPPORT FOR PEDIATRIC PATIENTS.
2023
$173K
TAU AND -AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN
2023
Funded by
$1.9B from 315 funders · 1,050 grants · 2016–2024
Mass General Brigham Incorporated &
$1.1B · 6 grants · 2017–2023
Fidelity Investments Charitable Gift Fund
$160.1M · 7 grants · 2018–2023
Wounded Warrior Project Inc
$77.3M · 6 grants · 2017–2023
President and Fellows of Harvard College
$76.9M · 12 grants · 2017–2023
The Broad Institute Inc
$71.4M · 8 grants · 2017–2023
Alzheimer's Disease Research Foundation
$31.0M · 95 grants · 2018–2024
Fidelity Non-Profit Management
$26.3M · 3 grants · 2020–2024
Donor Advised Charitable Giving Inc
$20.4M · 7 grants · 2017–2023
Details
EIN041564655
NTEE codeE21
Subsection03
Ruling date2010-11